Medical Devices & Technology

New York – September 16, 2026 -- NYU Langone Health's Perlmutter Cancer Center has named Sean L. Berry, PhD, vice chair of physics and dosimetry in its Department of Radiation Oncology, recruiting a 20-year veteran of Memorial Sloan Kettering Cancer Center to lead treatment-planning quality and safety programs.

Berry moves from a regional physicist role overseeing multi-site radiation oncology operations

Before joining NYU Langone, Berry served as regional lead physicist and associate attending physicist at Memorial Sloan Kettering Cancer Center, managing clinical physics operations across outpatient sites in Westchester County, New York, and Bergen County, New Jersey. His duties included supervising faculty physicists, staff physicists and dosimetrists, regulatory readiness, accreditation activities, budget oversight, linear accelerator commissioning and standardizing radiation oncology practice across multiple locations.

Windham, N.H. – September 16, 2026 -- SQAIRZ, a biomechanically driven performance footwear company, has launched SQAIRZ Medical, a new division targeting fall risk among aging adults through a combined footwear and clinical assessment platform.

Fall injuries cost the U.S. healthcare system more than $80 billion annually

One in four U.S. adults over age 65 falls at least once a year, a figure that rises to one in two for adults over 80, according to SQAIRZ. The company positions SENTRX, its purpose-built Balance & Stability footwear, as the centerpiece of a broader clinical framework aimed at reducing that risk.

Princeton, N.J. – – September 16, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.

CEO and CFO to join fireside chat on September 14

Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.

Concord, Mass. – September 16, 2026 -- OnPoint Surgical's augmented reality navigation system placed pedicle screws with a positional error of 1.1 mm and an angular error of 1.3°, figures 2 to 5 times smaller than those reported for competing navigation and robotic platforms, according to a peer-reviewed study published in the Journal of Spine Surgery.

Chicago – September 16, 2026 -- Prevent Blindness will present its 2027 Person of Vision Award to Reade Fahs, Executive Chairman of National Vision Holdings, Inc., the nation's leading eye-health advocacy organization announced.

Gala set for September 16, 2026, at The Venetian Resort in Las Vegas during Vision Expo

The award ceremony will coincide with Vision Expo, with all proceeds directed toward Prevent Blindness's sight-saving programs.

Fahs led National Vision for 23 years, building one of the largest U.S. optical retail chains

Fahs took the helm of National Vision in 2002 and served as CEO through 2025 before moving into the Executive Chairman role. Under his leadership, the company's portfolio expanded to include America's Best, Eyeglass World, Vista Optical and DiscountContacts.com.

Miami – September 16, 2026 -- Nicklaus Children's Hospital Heart Institute has completed one of the first transcatheter-based Fontan procedures performed in the United States, allowing a 2-year-old patient with double-outlet right ventricle to avoid an additional open-heart surgery. The child, born with a complex congenital heart defect, is recovering at home following the procedure.

Catheter-based technique replaces traditional open-heart surgery for Fontan completion

The care team used a catheter-based approach, guiding specialized equipment through a blood vessel to complete the child's Fontan circulation rather than performing conventional open-heart surgery. The Fontan procedure is typically the final stage in a multi-step surgical series for children born with single-ventricle heart defects, rerouting oxygen-poor blood from the body directly to the lungs without passing through a pumping chamber.

Valencia, Calif. – September 15, 2026 -- Bioness Medical, Inc. and OneStep have struck a partnership that lets clinicians measure patient gait and mobility using only a smartphone, both in clinic and in daily life, the companies announced.

Data from 300 patients shows measurable gains in walking speed and stride length

More than 300 patients were evaluated on OneStep's gait analysis platform to gauge the immediate impact of functional electrical stimulation from Bioness' L300 Go and L300 Go Plus systems. Among adults using the L300 Go Plus, stride length increased by 5.9 cm and walking velocity rose from 0.68 to 0.74 m/s, with parallel gains in overall and symmetry-based gait scores.

Delray Beach, Fla. – – September 15, 2026 -- The global High Flow Nasal Cannula (HFNC) market is projected to grow from USD 0.94 billion in 2026 to USD 1.44 billion by 2031, a compound annual growth rate of 8.9%, according to MarketsandMarkets.

North America leads a market shifting toward recurring consumables revenue

North America held the largest regional share of the HFNC market in 2025, supported by advanced critical-care infrastructure and established manufacturers. By product, consumables and accessories outpaced systems in market share, while adults represented the largest patient-type segment. Acute respiratory failure treatment led application demand, and hospitals remained the dominant end-user category due to intensive care unit and emergency department volumes.

Fremont, Calif. – September 15, 2026 -- Q'Apel Medical has launched the Lynx Aspiration Catheter System in the United States, expanding its neurovascular portfolio into the aspiration category for mechanical thrombectomy, the standard of care for acute ischemic stroke caused by vessel occlusion.

Lynx becomes the second Q'Apel product built on proprietary QLCT technology

The Lynx system marks the second device to feature Q'Apel's proprietary Q'Apel Laser Cut Tube (QLCT) technology, following the company's earlier product on this engineering platform. The catheters use a bimetal shaft design with an open-spaced nitinol structure intended to balance proximal support with distal flexibility while resisting kinking during navigation through complex cerebrovascular anatomy.

Louisville, Ky. – September 14, 2026 -- Induction Therapies and Collagen P.I.N., in partnership with aesthetic physician Dr. Shino Bay Aguilera, released new clinical findings on a treatment protocol combining Collagen P.I.N. microneedling with PRX8, a plant-derived exosome serum, for melasma in a patient with Fitzpatrick skin type V.

Patient shows sustained improvement after four treatments over eight weeks

The case involved a woman with longstanding facial melasma who had previously used topical hydroquinone and tranexamic acid without full resolution. She underwent four Collagen P.I.N. treatments over an eight-week period, with TRUExosomes PRX8 Plant-Exo Stimulation Serum applied after each session and daily sunscreen maintained throughout.

Visible improvement in the appearance of melasma was observed across the treatment course and persisted at the two-week follow-up after the final treatment, with no adverse reactions reported.